Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 10 2020
Historique:
received: 11 12 2019
accepted: 13 10 2020
entrez: 27 10 2020
pubmed: 28 10 2020
medline: 22 12 2020
Statut: epublish

Résumé

This study aimed to explore differences in vascular and structural parameters using optical coherence tomography angiography in patients with type 1 diabetes (DM1) with mild signs of diabetic retinopathy (DR) over a two-year follow-up period. Parafoveal vessel density (PVD) and foveal avascular zone (FAZ) area were analyzed. The thickness of three predefined retinal slabs was measured, including the inner limiting membrane (ILM)-inner plexiform layer (IPL), IPL-inner nuclear layer (INL), and the IPL-outer nuclear layer (ONL). Twenty-two patients with DM1 and 21 controls were included. There was no significant difference in the FAZ area, perimeter and acircularity index between cohorts over time. Baseline superficial capillary plexus PVD was approximately 10% lower in patients with diabetes than in controls (p = 0.001), and was 12% lower at 2 years (p = 0.002). There was no difference in the annual linear trend between the groups (- 0.5% in diabetics vs. controls, p = 0.736). Baseline deep capillary plexus (DCP) PVD was slightly lower in diabetics than in controls (- 4.4%, p = 0.047) and the difference increased at 2 years (- 12.6%, p < 0.001). The annual linear trend was - 2.7% in diabetic patients compared to controls (p = 0.009)

Identifiants

pubmed: 33106539
doi: 10.1038/s41598-020-75416-8
pii: 10.1038/s41598-020-75416-8
pmc: PMC7589477
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18266

Commentaires et corrections

Type : ErratumIn

Références

Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Acta Diabetol. 2019 Dec;56(12):1275-1282
pubmed: 31401734
World J Diabetes. 2010 May 15;1(2):57-64
pubmed: 21537428
Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2395-402
pubmed: 25897021
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2328-33
pubmed: 15980218
Acta Diabetol. 2017 May;54(5):489-497
pubmed: 28238189
Curr Diab Rep. 2011 Aug;11(4):253-64
pubmed: 21611764
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421
JAMA Ophthalmol. 2016 Apr;134(4):367-73
pubmed: 26795548
Mol Vis. 2010 Dec 02;16:2524-38
pubmed: 21151599
Diabetes Care. 2003 Apr;26(4):1224-9
pubmed: 12663601
JAMA. 2007 Aug 22;298(8):902-16
pubmed: 17712074
PLoS One. 2019 Jul 18;14(7):e0219164
pubmed: 31318880
Arch Ophthalmol. 1987 Jun;105(6):810-4
pubmed: 3579713
BMJ Open Diabetes Res Care. 2015 Feb 17;3(1):e000044
pubmed: 25713725
Diabetes Care. 2004 Oct;27(10):2540-53
pubmed: 15451934
Acta Ophthalmol. 2017 Dec;95(8):e751-e755
pubmed: 28211261
Arch Ophthalmol. 2004 Apr;122(4):546-51
pubmed: 15078673
Retina. 2019 Mar;39(3):435-445
pubmed: 29206758
Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1519-26
pubmed: 18604548
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
JAMA. 2003 Oct 15;290(15):2057-60
pubmed: 14559961
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO307-BIO315
pubmed: 29059262
Ophthalmology. 1991 May;98(5 Suppl):807-22
pubmed: 2062514
Retina. 2017 Jan;37(1):11-21
pubmed: 27557084
J Diabetes Res. 2019 Jun 12;2019:2547216
pubmed: 31281849
Br J Ophthalmol. 1990 Feb;74(2):106-8
pubmed: 2310723
Acta Ophthalmol. 2018 Mar;96(2):e264-e265
pubmed: 28887911
Diabetes Care. 2008 Apr;31(4):761-3
pubmed: 18184895
Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):873-9
pubmed: 26344729
Am J Ophthalmol. 2015 Jan;159(1):53-63.e1-2
pubmed: 25244976
Ophthalmology. 2015 Feb;122(2):367-74
pubmed: 25439595
Ophthalmology. 2009 Mar;116(3):461-7
pubmed: 19168222
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):20
pubmed: 32181799
Lancet Diabetes Endocrinol. 2019 Feb;7(2):140-149
pubmed: 30005958
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2167-2176
pubmed: 29801151
Sci Rep. 2017 Feb 10;7:42201
pubmed: 28186181
Am J Ophthalmol. 2015 Jul;160(1):35-44.e1
pubmed: 25896459
Ophthalmology. 2019 Dec;126(12):1675-1684
pubmed: 31358386
N Engl J Med. 2012 Mar 29;366(13):1227-39
pubmed: 22455417
Diabetologia. 2011 Mar;54(3):690-8
pubmed: 21116609
Diabetes Care. 2009 Mar;32(3):410-5
pubmed: 19074992
Br J Ophthalmol. 1995 Apr;79(4):362-7
pubmed: 7742285
J Diabetes Complications. 2004 May-Jun;18(3):160-4
pubmed: 15145327
Diabetes Care. 1990 Oct;13(10):1034-8
pubmed: 2209299
J Diabetes Res. 2013;2013:905058
pubmed: 23841106
Biomed Opt Express. 2016 Feb 09;7(3):816-28
pubmed: 27231591
Ophthalmologica. 2017;237(4):223-231
pubmed: 28391270
Arch Ophthalmol. 2004 Apr;122(4):552-63
pubmed: 15078674
J Biomed Opt. 2010 Jan-Feb;15(1):016029
pubmed: 20210473
Exp Eye Res. 2015 Jun;135:134-45
pubmed: 25728136
Retina. 2015 Nov;35(11):2377-83
pubmed: 26457396
Ophthalmic Res. 2015;54(3):118-23
pubmed: 26315560
J Anat. 1999 Jan;194 ( Pt 1):89-100
pubmed: 10227670
Am J Ophthalmol. 2013 Oct;156(4):684-92
pubmed: 23891332
Ophthalmology. 2008 Nov;115(11):1869-75
pubmed: 18584872
Curr Eye Res. 2015 Feb;40(2):234-46
pubmed: 25545999
Am J Ophthalmol. 2016 Feb;162:121-132.e1
pubmed: 26562176
Endocrine. 2019 Sep;65(3):542-549
pubmed: 31327157
Acta Diabetol. 2017 Jul;54(7):695-702
pubmed: 28474119
Br J Ophthalmol. 2008 Dec;92(12):1656-60
pubmed: 18829632
Ophthalmic Res. 2013;50(2):108-12
pubmed: 23838724

Auteurs

Fabio Scarinci (F)

Department of Ophthalmology, IRCCS-Fondazione Bietti, Rome, Italy. fabioscarinci@gmail.com.

Fabiana Picconi (F)

Unit of Endocrinology, Diabetes and Metabolism, S. Giovanni Calibita Fatebenefratelli Hospital, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Gianni Virgili (G)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze and AOU Careggi, Florence, Italy.

Monica Varano (M)

Department of Ophthalmology, IRCCS-Fondazione Bietti, Rome, Italy.

Paola Giorno (P)

Department of Ophthalmology, IRCCS-Fondazione Bietti, Rome, Italy.

Simona Frontoni (S)

Unit of Endocrinology, Diabetes and Metabolism, S. Giovanni Calibita Fatebenefratelli Hospital, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Mariacristina Parravano (M)

Department of Ophthalmology, IRCCS-Fondazione Bietti, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH